Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 131.67M | 158.14M | 150.71M | 168.11M | 203.00M |
| Total Depreciation and Amortization | 64.25M | 63.99M | 64.71M | 65.11M | 66.28M |
| Total Amortization of Deferred Charges | 46.60M | 46.60M | 46.60M | 46.60M | 44.30M |
| Total Other Non-Cash Items | 42.60M | 42.44M | 41.33M | 29.27M | 4.04M |
| Change in Net Operating Assets | -20.27M | -6.45M | 134.00K | -10.11M | -10.74M |
| Cash from Operations | 264.85M | 304.72M | 303.49M | 298.98M | 306.88M |
| Capital Expenditure | -44.10M | -50.41M | -58.46M | -62.88M | -55.73M |
| Sale of Property, Plant, and Equipment | 1.79M | 1.79M | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -3.28M | -169.71M | -169.71M |
| Divestitures | -- | -- | -- | -- | 0.00 |
| Other Investing Activities | -2.09M | -3.34M | -8.87M | 29.55M | 26.46M |
| Cash from Investing | -44.40M | -51.97M | -70.60M | -203.03M | -198.98M |
| Total Debt Issued | 38.00M | 0.00 | 65.00M | 225.00M | 225.00M |
| Total Debt Repaid | -97.00M | -147.00M | -205.00M | -256.00M | -206.00M |
| Issuance of Common Stock | 68.45M | 71.91M | 71.64M | 60.94M | 46.42M |
| Repurchase of Common Stock | -182.36M | -82.20M | -86.67M | -101.91M | -101.55M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -50.63M | -50.63M | -50.45M | -50.42M | -50.39M |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -223.55M | -207.92M | -205.48M | -122.40M | -86.53M |
| Foreign Exchange rate Adjustments | 3.85M | 2.58M | 11.48M | -2.33M | -8.74M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 755.00K | 47.42M | 38.88M | -28.78M | 12.63M |